EEG-Guided Analgesia for Delirium

(ALPHA-DEX Trial)

PS
TZ
Overseen ByTuan Z. Cassim, BA
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if adjusting anesthesia based on brain activity can improve recovery for older adults after surgery. Researchers focus on how certain pain medications affect brain waves during surgery and whether this reduces confusion or delirium afterward. Participants will receive different types of anesthesia management, including standard care and personalized adjustments, known as "Alpha Optimization." Individuals aged 60 or older, who can give consent, and are scheduled for a planned surgery lasting at least two hours (excluding head or neck procedures) may be eligible. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance surgical recovery for older adults.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you use opioids for chronic pain or take certain medications like carbamazepine or phenytoin, you cannot participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that using EEG, a test that measures brain activity, to guide anesthesia can help adjust the amount of pain medication and anesthetic gas during surgery. Previous studies have examined how this method affects patient safety and recovery.

One study examined how changing anesthesia based on EEG readings could reduce complications, such as breathing or heart issues, during surgery. The results suggested that this approach might improve patient recovery after surgery. Another study found that using technology to personalize anesthesia can enhance patient safety and recovery.

These studies support the idea that EEG-guided anesthesia is generally well-tolerated and may aid in managing recovery after surgery. While more research is always helpful, current findings indicate that this approach is safe for use in humans.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a novel approach to optimizing anesthesia for better recovery in older patients. Unlike standard practices that don't tailor the depth of anesthesia based on real-time brain activity, this method uses EEG-guided titration to adjust anesthetic and opioid levels. By focusing on individual brainwave patterns, the hope is to enhance early neurocognitive recovery, potentially reducing postoperative confusion and cognitive decline. This personalized technique could set a new standard in anesthesia care, especially for older adults who are more vulnerable to anesthesia-related cognitive issues.

What evidence suggests that this trial's treatments could be effective in reducing delirium following surgery?

Research has shown that monitoring brain activity, specifically alpha waves, during surgery might aid recovery. Studies have found a link between stronger alpha waves and better post-surgery recovery. For instance, higher alpha wave activity under anesthesia is associated with a lower risk of delirium, a state of confusion some experience after surgery. One study discovered that older adults with stronger alpha waves required less anesthesia, potentially leading to an easier recovery. This trial will compare different approaches, including Alpha Optimization and Routine Care, to determine if adjusting anesthesia based on alpha waves can help patients recover more smoothly after surgery.16789

Who Is on the Research Team?

PS

Paul S. Garcia, MD, PhD

Principal Investigator

Columbia University

Are You a Good Fit for This Trial?

This trial is for adults aged 60 or older who can consent to participate, are having elective non-cardiac surgery (not involving the head or neck) with general anesthesia planned for at least 2 hours. It's not for those who refuse participation, use illicit substances or excessive alcohol, have chronic pain needing opioids, or take enzyme inducers like carbamazepine.

Inclusion Criteria

Adults aged 60 years or over
Has capacity to provide informed consent
Undergoing elective non-cardiac surgery, which does not involve the head or neck, with planned volatile-based general anesthesia of expected duration of at least 2 hours

Exclusion Criteria

Refusal by patient or case anesthesiologist responsible for patient's care
You use illegal drugs or drink alcohol excessively.
You have long-term pain that requires opioids or are taking certain medications that can interfere with the study drug.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo EEG-guided analgesic titration during general anesthesia to improve early neurocognitive recovery

During surgery
1 visit (in-person)

Postoperative Monitoring

Participants are monitored for delirium and pain in the PACU using 3D-CAM, CAM-ICU, and NRS assessments

Up to 24 hours post-surgery

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Alpha Optimization
  • Emergence from anesthesia with propofol

Trial Overview

The study aims to determine if adjusting analgesic medication based on EEG alpha power during anesthesia can reduce delirium after surgery. Participants will emerge from anesthesia using a drug called Dexmedetomidine while optimizing their brain's alpha waves.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Active Control

Group I: Maintenance-Alpha Optimization / Wake from DexmedetomidineExperimental Treatment2 Interventions
Group II: Maintenance-Alpha Optimization / Wake from SevofluraneActive Control1 Intervention
Group III: Maintenance-Routine Care / Wake from DexmedetomidineActive Control1 Intervention
Group IV: Maintenance-Routine Care / Wake from SevofluraneActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

Citations

Intraoperative Frontal Electroencephalogram Alpha Power Is ...

Our primary outcome was postoperative mortality, extracted from the patient's electronic health record or the State of Massachusetts death registry, and ...

Lower alpha frequency of intraoperative frontal EEG is ...

A strong age-dependent negative correlation has been reported between the peak oscillatory frequency of alpha waves and end-tidal anesthetic concentration, with ...

Modulation Of Frontal EEG Alpha Oscillations During ...

Intraoperative monitoring of frontal electroencephalogram (EEG) has been associated with postoperative delirium and poor outcomes. However, the efficacy of ...

Intraoperative Frontal EEG Alpha Power is Associated with ...

Our primary outcome was post-operative mortality, measured from date of surgery to date of death or last follow-up. Secondary outcomes included ...

Propofol Requirement and EEG Alpha Band Power During ...

The objective of this present study is to evaluate the relationship between intraoperative EEG, especially the alpha band power, effective ...

Artificial intelligence in anesthesia and perioperative medicine

AI improves individualized treatment, patient safety and postoperative recovery through biomarker identification and anesthetic protocol optimization.

A 6-Year Retrospective Cohort Study

This study investigates perioperative complications as primary outcomes, focusing on respiratory, cardiovascular, and cerebrovascular issues, as ...

(PDF) Artificial Intelligence In Anesthesia Management

Objective: The objective of this study is to explore the role and perceptions of Artificial Intelligence (AI) in anesthesia management, ...

A Scoping Review of Artificial Intelligence in Perioperative ...

Current research highlights the growing integration of AI in anesthesiology, spanning preoperative risk assessment, intraoperative management, and postoperative ...